At Sur Access, we are a dynamic team of highly specialized Market Access consultants, spearheaded by Dr. Sanja Fitzgerald. We offer a focused, personalized, and impactful alternative to large consulting firms, combining deep individual expertise with the strength of strategic partnerships to deliver comprehensive solutions.

As founder and lead consultant, Dr. Sanja Fitzgerald offers a blend of scientific rigor and extensive commercial experience. With a PhD in Computational Chemistry (ETH Zurich) and a 15-year career in biotech (product development, innovation, commercial leadership), Sanja provides valuable insight into navigating complex market access landscapes.

Sanja serves as Technology Officer for the HTAi Rare Disease Interest Group. In this role, she is at the center of global discussions and initiatives, ensuring she is fully informed on efforts to improve patient access for innovative rare disease treatments within the international HTA framework.

Her core expertise spans Europe, with a local expertise in Switzerland and Croatia. She specializes in developing and implementing strategic market access solutions for oncology, rare disease products, and other therapeutic areas.

Our Collaborative Strength: Extending Your Reach

Unlike larger consultancies, we offer a direct, hands-on approach, ensuring your specific needs are met with tailored and effective strategies. When projects require broader capabilities, specialized local knowledge, or distinct regulatory expertise beyond our core, we seamlessly integrate the strengths of our trusted network of partners. This collaborative model ensures:

• Tailored Solutions: We build the right team for your unique challenge, rather than fitting your needs into a predefined structure.
• Comprehensive Support: From initial market access strategy to local regulatory submissions and even company establishment in Switzerland, our network covers the full spectrum.
• Agility & Efficiency: Our lean structure allows for rapid response and efficient project execution.

We are available for a range of engagements, including interim support, project-based collaborations, and deliverable-based assignments.

Our Collective Expertise

Our combined expertise ensures a holistic approach to your market access challenges:

• Swiss Market Access & Reimbursement: Deep understanding of the complexities of Swiss pricing and reimbursement (P&R) dossier submissions to BAG, alongside strong knowledge of local reimbursement laws and market dynamics.
• Market Access Strategy & Pricing: Developing robust global market access strategies, value-based pricing scenarios, and effective reimbursement strategies for European markets, with a particular focus on Switzerland.
• Health Economics & Data Analysis: Leveraging strong analytical skills in market intelligence, payer research, revenue forecasting, and the application of advanced methodologies like Indirect Treatment Comparisons (ITCs) to support strategic decision-making for PICO development and Joint Clinical Assessments (JCAs).
• Stakeholder Engagement & Communication: Building and maintaining strong relationships with key stakeholders, coupled with excellent communication and presentation abilities, particularly within the HTA and policy environment.
• Regulatory & Corporate Understanding: Effectively bridging the gap between regulatory marketing authorization and market access requirements, including support for establishing local company presence in Switzerland through our partners.